Laurence Dumon

Title: Innovations by Laurence Dumon

Introduction

Laurence Dumon is a notable inventor based in Saint-Beauzire, France. She has made significant contributions to the field of vaccine development through her innovative research and patents. With a focus on multimeric complexes of antigens, her work has the potential to enhance vaccine efficacy.

Latest Patents

Laurence Dumon holds 2 patents related to her groundbreaking work. Her latest patents include methods of using multimeric complexes of antigens and an adjuvant. The invention involves a product that comprises a C4bp domain of non-mammalian origin, particularly SEQ ID NO:1, SEQ ID NO:23, or SEQ ID NO:37, or a variant thereof, along with an antigen. This product is ideally in the form of a fusion protein. The chicken C4bp domain of SEQ ID NO:1 and SEQ ID NO:23 is also described. The antigens include monomeric antigens such as malarial and influenza antigens. The C4bp domain facilitates the assembly of multimeric complexes of the antigen, which are useful as vaccines.

Career Highlights

Laurence Dumon has established herself as a key figure in her field through her innovative research and patent contributions. Her work at Imaxio has positioned her at the forefront of vaccine technology, where she continues to explore new methodologies for improving vaccine formulations.

Collaborations

Laurence has collaborated with notable colleagues, including Fergal Hill and Jean-Baptiste Marchand. These collaborations have further enriched her research and contributed to the advancement of vaccine development.

Conclusion

Laurence Dumon's innovative work in the field of vaccine development showcases her dedication to improving public health through science. Her patents and collaborations reflect her significant impact on the industry.